Blair Gibson

Report to Chief Marketing Officer. Design and implement a global portfolio management capability for the $27-billion prescription business. · Accountable for the development of an overall Global Human Health (GHH)-wide strategic planning process and portfolio management framework for marketed brands by developing and analyzing a series of critical brand-performance and market metrics for maximizing return on sales-and-marketing investment . Analyze product resource allocation, recommend investment

My role was to drive global marketing and branding of new products for the CV and Diabestes portfolio from phase III to launch. Provide data analysis to support decision-making. Build and maintain network of external experts and advocates. Evaluate and quantify in-licensing and acquisition opportunities; identify market trends; make recommendations to update the strategy. Sanofi- Aventis is a $35 billion pharmaceutical manufacturer headquartered in France with global marketing based in the US. .

Led the strategic and tactical planning process, I worked with brand teams to strengthen planning capabilities, and life cycle management. I developed the company's portfolio management process. Acquired by Pfizer in 2003. Accomplishments · Launch Optimization: The success of our global launches was inconsistent. Many key functional support areas had not been addressed in the launch plans. Seeing this pattern, I designed and implemented a Launch Readiness Process for the Inspr